Provides a glimmer of hope for the treatment of Covid-19 caused by the coronavirus.

An experiment conducted by researchers at Oxford University provides a glimmer of hope for the treatment of Covid-19 caused by the corona virus.

The vaccine developed by a well-known university in the UK was able to protect six experimental monkeys from corona virus infection in large numbers.Researchers at the National Institute of Health at Rocky Mountain Laboratory injected six rhesus monkeys with the vaccine from Oxford.After that, the six monkeys were left exposed to large numbers of Covid-19. So many viruses have caused other monkeys in the laboratory to get sick, the New York Times reported.

1 of 4 pages

After 28 days had passed, the six monkeys injected with the vaccine from Oxford were in good health.

According to Dr. Vincent Munster, who led the Oxford vaccine trial, said rhesus monkeys are the closest mammals to humans.Now the vaccine will be tested on humans. The trial involved more than 6,000 people by the end of next month.If the trial proves to be safe and effective, researchers are optimistic that the vaccine will be available in September 2020.

2 of 4 pages

Previously, the Jenner Institute in the United Kingdom had begun developing a vaccine for the corona virus. They conducted a trial for a type of virus early last year that proved to be harmless to humans.SinoVac, a research company based in China also made progress after testing rhesus macaques.

Provides a glimmer 2020
Provides a glimmer 2020 of hope for the treatment of Covid-19 caused by the corona virus.

The company has also recently begun clinical trials of the corona virus vaccine against 144 humans.

3 of 4 pages

Research: Corona Virus Can Live in Patients’ Eyes for 20 Days

A rare event happened to a Covid-19 patient. Although declared recovered, in the eyes of these patients still leave traces of the corona virus that causes Covid-19.According to researchers, the latest findings show how important it is to wash hands with soap and not touch the nose, mouth and eyes.

The 65-year-old patient is the first positive case of Covid-19 in Italy. He showed signs of conjunctivitis after being treated January 23 in hospital.Conjunctivitis is a condition of red eye due to inflammation of the membrane lining the surface of the eyeball and inner eyelid.On the third day at the hospital, the woman submitted the results of an eye swab test. It turned out that the level of virus particles detected in the swab test results was very high, the researchers said.

4 of 4 pages

Tential to be Contagious

From the results of the next swab test it was discovered that the virus had multiplied itself. This shows that his eyes could potentially transmit the corona virus.”We found that eye fluid from patients infected with SARS-CoV-2 can contain an infectious virus, and therefore can be a potential source of infection,” the researchers wrote.The virus remained detected in his eyes until at least the 20th day. Although it had disappeared, but the virus reappeared seven days later.

The researchers noted that the virus was able to stay in the eyes of patients longer than in the nose.”RNA from SARS-CoV-2 was detected in the eye swab a few days after it was not detected in the nasal swab,” the researchers wrote in the findings, written in the journal Annals of Internal Medicine .These findings emphasize the importance of taking precautionary measures to transmit the corona virus, such as not touching the nose, mouth and eyes and washing hands frequently with soap.

You May Also Like

Leave a Reply